Xiang Sun1, Yan Xu1, Yuanyuan Zhu1, Fenyang Tang1. 1. Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province, China.
Abstract
BACKGROUND: In response to the coronavirus disease 2019 (COVID-19) pandemic, many countries have implemented mitigating non-pharmaceutical interventions. We investigated the impact of these interventions and changes in public behavior on the incidences of selected vaccine-preventable diseases (VPDs) during the COVID-19 pandemic in the eastern of China. METHODS: From routine monitoring data collected in the capital of eastern China's Jiangsu Province, we extracted and analyzed the incidences of influenza; hand, foot and mouth disease (HFMD); varicella; mumps; pertussis; and hepatitis B. We also investigated the changes in public behavior during the COVID-19 pandemic through telephone interviews and questionnaire surveys. RESULTS: Compared with the baseline (2017-2019), the incidences of all VPDs except influenza declined significantly in 2020 (HFMD decreased by 79.92%, varicella decreased by 7.71%, mumps decreased by 2.03%, pertussis decreased by 78.91%, and hepatitis B decreased by 0.31%). The reduction in reported cases in children (0-14 years) was greater than that in adults, and pertussis had the largest reduction (approximately 80%) in children. Influenza peaks in winter; in the three years before the COVID-19 pandemic, Influenza rates took an average of 10 weeks to recede to their lowest levels after the Spring Festival, while in 2020, this took only 1 week. A total of 366 outbreaks with 20,205 cases were reported during the COVID-19 pandemic. Among the participants in the study, 94.2% of the interviewees avoided going to high-risk areas, 82.4% avoided going to crowded places, 92.9% wore masks when going out,88.4% washed their hands frequently, and 67.9% maintained social distance. CONCLUSIONS: Our study showed significant reductions in the incidences of VPDs after the implementation of a series of non-pharmaceutical interventions during the COVID-19 pandemic.
BACKGROUND: In response to the coronavirus disease 2019 (COVID-19) pandemic, many countries have implemented mitigating non-pharmaceutical interventions. We investigated the impact of these interventions and changes in public behavior on the incidences of selected vaccine-preventable diseases (VPDs) during the COVID-19 pandemic in the eastern of China. METHODS: From routine monitoring data collected in the capital of eastern China's Jiangsu Province, we extracted and analyzed the incidences of influenza; hand, foot and mouth disease (HFMD); varicella; mumps; pertussis; and hepatitis B. We also investigated the changes in public behavior during the COVID-19 pandemic through telephone interviews and questionnaire surveys. RESULTS: Compared with the baseline (2017-2019), the incidences of all VPDs except influenza declined significantly in 2020 (HFMD decreased by 79.92%, varicella decreased by 7.71%, mumps decreased by 2.03%, pertussis decreased by 78.91%, and hepatitis B decreased by 0.31%). The reduction in reported cases in children (0-14 years) was greater than that in adults, and pertussis had the largest reduction (approximately 80%) in children. Influenza peaks in winter; in the three years before the COVID-19 pandemic, Influenza rates took an average of 10 weeks to recede to their lowest levels after the Spring Festival, while in 2020, this took only 1 week. A total of 366 outbreaks with 20,205 cases were reported during the COVID-19 pandemic. Among the participants in the study, 94.2% of the interviewees avoided going to high-risk areas, 82.4% avoided going to crowded places, 92.9% wore masks when going out,88.4% washed their hands frequently, and 67.9% maintained social distance. CONCLUSIONS: Our study showed significant reductions in the incidences of VPDs after the implementation of a series of non-pharmaceutical interventions during the COVID-19 pandemic.
Entities:
Keywords:
COVID-19; incidence; novel coronavirus; social distancing; wearing masks
Authors: Benjamin J Cowling; Diane M W Ng; Dennis K M Ip; Quiyan Liao; Wendy W T Lam; Joseph T Wu; Joseph T F Lau; Sian M Griffiths; Richard Fielding Journal: J Infect Dis Date: 2010-09-15 Impact factor: 5.226
Authors: Leisha D Nolen; Sara Seeman; Dana Bruden; Joe Klejka; Chris Desnoyers; James Tiesinga; Rosalyn Singleton Journal: Clin Infect Dis Date: 2021-06-15 Impact factor: 9.079
Authors: Alexandra Teslya; Thi Mui Pham; Noortje G Godijk; Mirjam E Kretzschmar; Martin C J Bootsma; Ganna Rozhnova Journal: PLoS Med Date: 2020-07-21 Impact factor: 11.069
Authors: Hongxia Peng; Zhenhua Chen; Lin Cai; Juan Liao; Ke Zheng; Shuo Li; Xueling Ren; Xiaoxia Duan; Xueqin Tang; Xiao Wang; Lu Long; Chunxia Yang Journal: BMC Public Health Date: 2022-05-17 Impact factor: 4.135
Authors: Ming-Zhu Xie; Lin-Yi Chen; Yan-Na Yang; Yan Cui; Si-Hui Zhang; Tian-Shuo Zhao; Wan-Xue Zhang; Juan Du; Fu-Qiang Cui; Qing-Bin Lu Journal: Front Med (Lausanne) Date: 2022-04-25